Valued at a market cap of $230 billion, Thermo Fisher Scientific Inc. (TMO) is a global leader in serving the life sciences industry, providing the tools, technologies, diagnostics, laboratory supplies, and outsourced services to conduct research, develop medicines, and improve patient care. The Waltham, Massachusetts-based company portfolio spans reagents and consumables, analytical and laboratory instruments, genetic and molecular biology technologies, diagnostic products, and biopharmaceutical development and manufacturing services.
Companies valued at $200 billion or more are generally classified as “mega-cap” stocks, and Thermo Fisher Scientific fits this criterion perfectly.